Greenphage
Clapiers
About Greenphage
Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions to support its phage therapy efforts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: greenphage.com
Industries & Categories
Biotechnology, Clinical Trials, Medical, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/greenphage-86585 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.